On (b)(6) 2018 an eye care provider (ecp) called to provide additional information regarding a complaint received from a patient (pt) regarding a current issue with the acuvue oasys 1 day brand contact lenses.During the call, the pts ecp reported the pt was diagnosed in (b)(6) 2018 with a small corneal ulcer while wearing the acuvue oasys 1 day brand contact lenses.The ecp also reported the pt had sjogren's syndrome.On 12jun2018 a call was received from the pts treating ecp who provided additional information: pt was seen on (b)(6) 2018 with complaints of redness, discomfort and pt saw a ¿white spot¿ on the od.Pt was diagnosed with ¿suspicion of corneal ulcer in superior cornea, more peripheral¿.Pt was ¿treated as infectious vs.Sterile with gatafloxacin q 2 h until (b)(6) 2018¿.Pt was seen in the clinic the following day and diagnosed with ¿staphylococcus marginal ulcer¿ and the pt was prescribed prednisolone acetate bid.The ecp reported no culture was obtained and pt was treated with their ¿standard of care¿.The ecp reported that ¿all ulcers are treated aggressively and it is not certain if ulcer is infectious or a hypersensitivity to staph bacteria¿.The ecp reported that prednisone is typically added when they believe ¿it may be a hypersensitivity to the staph bacteria¿.The pt was seen on (b)(6) 2018 and the gatafloxacin was decreased to qid and prednisone decreased to qd; ulcer healed; no infiltrate; pts va without cl before and after the event is 20/40, no change in va.The ecp reported the pts last visit was on (b)(6) 2018 and it is unknown if the pt returned to contact lens wear.Multiple attempts were made to the pt for the suspect lot number and suspect product availability.It is unknown if the suspect product is available for return.No additional information has been received.If any further relevant information is received, a supplemental report will be filed.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|